NCT05942456View on ClinicalTrials.gov

Soluble B7-H3 as a Biomarker for Osteosarcoma

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

December 31, 2024

Conditions

BiomarkerProgressionOsteosarcomaSurveillance

Interventions

DIAGNOSTIC_TEST

ELISA: enzyme-linked immunosorbent assay

enzyme-linked immunosorbent assay

Trial Locations (1)

100044

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors

lead

Peking University People's Hospital

OTHER